Patent 7584087 was granted and assigned to Wyeth on September, 2009 by the United States Patent and Trademark Office.
A three-dimensional structure of human protein kinase C theta (PKCθ) can be used in methods of designing an agent that interacts with PKCθ. The agent can be an inhibitor of PKCθ activity.